Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.03.002Source: DataRank Database

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis is a research paper published in Journal of Cystic Fibrosis (2022). On theSindex it has a DataRank of 0. It has been cited 87 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access87 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: hybridTopics (42)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Adam J. Kimple ORCID,Jennifer L. Goralski ORCID,Mehdi Nouraie ORCID,Barton F. Branstetter ORCID,Amber D. Shaffer ORCID

Live enrichment

PubMed:35300931 PMC:PMC9470769

National Institutes of Health

Grant: BOMBER19R0

National Institutes of Health

Grant: KL2TR002490

NHLBI

Grant: K23HL131930

Cystic Fibrosis Foundation

Grant: ZEMKE16Q0

Cystic Fibrosis Foundation

Grant: ZEMKE19A0

NIDDK NIH HHS

Grant: P30 DK065988

National Institutes of Health

Grant: 5KL2TR002490-05

North Carolina Translational and Clinical Science Institute (NC TraCS) KL2

National Institutes of Health

Grant: 5K23HL131930-05

Nebulized Nitrite as a Novel Antimicrobial Therapy in Cystic Fibrosis

hybridLicense: cc-by-nc-nd

publisherhttp://www.cysticfibrosisjournal.com/article/S1569199322000510/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1569199322000510?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1569199322000510?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9470769

https://doi.org/10.1016/j.jcf.2022.03.002

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansCystic FibrosisSinusitisChloridesAminophenolsPyrazolesPyridinesPyrrolidinesIndolesQuinolonesCystic Fibrosis Transmembrane Conductance RegulatorMutationAdolescentAdultMiddle AgedChildBenzodioxolesYoung AdultChloride Channel Agonists

Keywords

SinusitisCystic FibrosisSinus DiseaseHighly Effective Modulator TherapyAdultIndolesPyrrolidinesAdolescentPyridinesCystic Fibrosis Transmembrane Conductance RegulatorMiddle AgedQuinolonesAminophenolsYoung AdultChloridesMutationHumansPyrazolesBenzodioxolesChildChloride Channel Agonists